Kintayl Capital’s Core Scientific CORZ Stock Holding History

Kintayl Capital’s Portfolio CORZ Stock Details CORZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-74,664	Closed	-$1.27M	–	57
2025 Q4	$1.09M	Sell	74,664 -495,390	-87%	-$8.64M	0.66%	39
2025 Q3	$10.2M	Buy	+570,054	New	+$8.36M	6.3%	6

Other funds holding CORZ

Situational Awareness San Francisco, California $13.7B AUM 334.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Jericho Capital Asset Management New York $6.76B AUM 88.1% 1-Year Est. Return

Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return

Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

Kintayl Capital's CORZ Position: Q1 2026 in Review

Kintayl Capital sold out of Core Scientific (CORZ) in Q1 2026, closing a stake of 74,664 shares — an estimated $1.27M sold.

Kintayl Capital first reported a position in CORZ in Q3 2025 and held it in 2 quarters. The position peaked at $10.2M in Q3 2025. 386 funds tracked by Wall St. Rank hold CORZ as of Q1 2026.

Kintayl Capital reported no remaining Core Scientific position as of Q1 2026 after selling out during the quarter.
Kintayl Capital sold 74,664 Core Scientific shares in Q1 2026, an estimated $1.27M.
Kintayl Capital first reported a position in Core Scientific in Q3 2025 and held it in 2 quarters.
Kintayl Capital's Core Scientific position peaked at $10.2M in Q3 2025.
386 funds tracked by Wall St. Rank held Core Scientific as of Q1 2026.

Based on Kintayl Capital's 13F filing for Q1 2026, filed 15 May 2026.